Targacept Reports Positive Trial Results
Shares of Targacept Inc. (Nasdaq: TRGT) surged $3.97 to $7.03 after the drug research company reported positive mid-stage results for its treatment of depression.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.